The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.125
Bid: 8.50
Ask: 9.75
Change: 0.00 (0.00%)
Spread: 1.25 (14.706%)
Open: 9.125
High: 9.125
Low: 9.125
Prev. Close: 9.125
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

17 Nov 2014 07:00

NORMAN BROADBENT PLC - Issue of Equity

NORMAN BROADBENT PLC - Issue of Equity

PR Newswire

London, November 14

17 November 2014 Norman Broadbent plc ("Norman Broadbent" or "the Company") Fundraising for re-modelling and accelerate growth Norman Broadbent, a leading provider of executive search, leadershipconsultancy and complementary recruitment services is pleased to announce thatit has raised £500,000 (the "Subscription") through the issue of 2,617,801 newordinary shares in the capital of the Company at a price of 19.1 pence pershare (the "Subscription Shares") to existing institutional and professionalinvestors. The Subscription is conditional upon admission of the SubscriptionShares to trading on AIM ("Admission"). The net proceeds of the Subscription amounting to £487,500 will be used to fundthe recent re-modelling of certain aspects of the contingent offering withinAGP and for working capital purposes generally. Pierce Casey, a Director of the Company, has agreed to subscribe for 469,144Subscription Shares as part of the Subscription. Following Admission and theissue of the Subscription Shares his holding in the enlarged issued sharecapital of the Company will be as follows: No. of Shareholding Percentage holding Subscription following of enlarged issued Shares Admission share capital Pierce Casey, Executive 469,144 3,682,242 21.14Chairman In addition, Jon Moulton, a substantial shareholder of the Company, has agreedto subscribe for 568,378 Subscription Shares. Following Admission, Mr Moultonwill be beneficially interested in a total of 3,781,476 ordinary shares,equivalent to 21.71 per cent. of the enlarged issued share capital of theCompany. Ennismore Fund Management LLP ("Ennismore"), a significant shareholder of theCompany has agreed to subscribe for 197,382 Subscription Shares. FollowingAdmission, Ennismore will be beneficially interested in a total of 1,313,203ordinary shares, equivalent to 7.54 per cent. of the enlarged issued sharecapital of the Company. Downing LLP ("Downing"), a substantial shareholder of the Company, has alsoagreed to subscribe for 1,382,897 Subscription Shares. Following Admission,Downing will be beneficially interested in a total of 4,354,122 ordinaryshares, equivalent to 25.00 per cent. of the enlarged issued share capital ofthe Company. Pursuant to the terms of Downing's participation in theSubscription, Downing has a right to appoint a non-executive director to theboard of directors of Norman Broadbent. Due to the fact that Pierce Casey is a Director of the Company and the size ofhis shareholding, his participation in the Subscription constitutes a relatedparty transaction as defined by the AIM Rules. The participations in theSubscription by Jon Moulton and Downing are also related party transactions asdefined by the AIM Rules due to the size of their shareholdings. The Directorsof the Company other than Mr Casey, having consulted with Sanlam Securities UKLimited, the Company's Nominated Adviser, consider that Mr Casey's, MrMoulton's, Ennismore and Downing's participations in the Subscription are fairand reasonable insofar as shareholders are concerned. Application will be made for the Subscription Shares to be admitted to tradingon AIM with Admission expected to become effective on 21 November 2014.Following Admission the Company will have 17,416,487 ordinary shares in issue.For the purposes of the Financial Conduct Authority's Disclosure andTransparency Rules ("DTRs"), the issued ordinary share capital of the Companyfollowing this allotment consists of 17,416,487 ordinary shares with votingrights attached (one vote per share). There are no shares held in treasury.This total voting rights figure may be used by shareholders as the denominatorfor the calculations by which they will determine whether they are required tonotify their interests in, or a change to their interest in, the Company underthe DTRs. Pierce Casey, Executive Chairman, commented: "As indicated in the Chairman's Statement accompanying the Interim Results forthe six months to 30 June 2014, issued on 30 September 2014 consideration wasbeing given regarding a re-modelling of aspects of the contingent offeringwithin AGP. This re-modelling is being effected and the proceeds of theSubscription will be used both for this purpose, coupled with acceleratedgrowth in other promising areas of the business. Trading across the group is currently satisfactory." For further information please contact: Norman Broadbent plc 020 7484 0000Pierce Casey / Sue O'Brien / James Webber Sanlam Securities UK Limited 020 7628 2200Simon Clements / Virginia Bull Notes to Editors Norman Broadbent plc is a leading provider of senior and board executive searchand leadership consultancy and assessment services. Through AGP the Group alsoprovides specialist contingent offerings, including RPO solutions. NormanBroadbent Interim Management provides a dedicated senior interim managementservice focussed on enhanced client returns on investment and long termbenefits. Connecting Corporates and Winning Work, now consolidated under theSocial Media Search brand, provides digital research to assist in houserecruitment as well as assisting professional service firms to drive sales bybespoke exploitation of social media. Headquartered in London, the Group alsohas offices in Los Angeles with a representative office in Singapore.

For further information visit www.normanbroadbent.com

Date   Source Headline
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM
20th May 20225:49 pmRNSIssue of Convertible Loan Notes
11th May 20224:16 pmRNSDirector resignation
18th Mar 20227:00 amRNSGrant of Options to Directors and Employees
2nd Mar 20227:00 amRNSFY2021 Trading Update
7th Feb 20227:00 amRNSBoard Changes
7th Dec 20213:50 pmRNSHolding(s) in Company
6th Dec 202110:18 amRNSSubscription
2nd Dec 20217:00 amRNSHolding(s) in Company
12th Nov 20212:30 pmRNSDirector/PDMR Shareholding
1st Nov 20217:00 amRNSAppointment of Group Managing Director
27th Sep 20217:02 amRNSSubscription Results and PDMR Dealing
27th Sep 20217:00 amRNSInterim Results for Six Months Ended 30 June 2021
12th Aug 20217:00 amRNSBoard Changes
12th Jul 20217:00 amRNSBoard Changes
25th Jun 202112:30 pmRNSResult of AGM
15th Jun 20217:00 amRNSAppointment of Executive Chairman
24th May 20217:00 amRNSFinal Results and Annual Accounts
13th May 202111:59 amRNSHolding(s) in Company
12th May 202112:17 pmRNSHolding(s) in Company
12th May 20219:39 amRNSHolding(s) in Company
19th Apr 202111:59 amRNSNotice of Results
19th Apr 202111:53 amRNSHolding(s) in Company
25th Jan 20217:00 amRNSFY2020 Trading Update
26th Nov 20207:00 amRNSFunding Update
23rd Nov 20204:54 pmRNSHolding(s) in Company
21st Oct 20201:45 pmRNSAppointments - Group Managing Director & Others
16th Oct 20201:00 pmRNSDirector/PDMR Shareholding & Concert Party Update
5th Oct 20203:01 pmRNSIssue of Equity
5th Oct 20207:00 amRNSAcquisition of minority interest in NBIMv
28th Sep 20207:00 amRNSInterim Results
27th Aug 202010:40 amRNSDirectorate Change
24th Aug 202010:59 amRNSDirector/PDMR Shareholding
28th Jul 202010:18 amRNSResult of AGM and Appointment of Chair
28th Jul 20207:00 amRNSAGM Statement and Trading Update
16th Jul 202010:35 amRNSHolding(s) in Company
29th Jun 20207:00 amRNSFinal Results and Annual Accounts
26th May 202011:32 amRNSDirector/PDMR Shareholding
18th May 202012:33 pmRNSDirector/PDMR Shareholding
18th May 20207:00 amRNSTrading Update
11th Mar 202012:00 pmRNSAppointment of CFO & COO
9th Mar 20207:00 amRNSChange of address
3rd Mar 20207:00 amRNSExpansion driven by increased client demand
28th Feb 20207:00 amRNSUpdate: Chief Financial Officer Succession
24th Jan 20207:00 amRNSTrading Update
10th Dec 20197:00 amRNSNorman Broadbent Group partners with UN Women UK
26th Sep 20197:00 amRNSInterim Results for six months ended 30 June 2019
9th Sep 20197:00 amRNSNew and Enhanced Working Capital Facility
23rd Aug 201911:31 amRNSHolding(s) in Company
23rd Aug 201910:51 amRNSShareholder Update and Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.